Immunohistochemical_JJ
study_NN
of_IN
c-fos-positive_JJ
lymphocytes_NNS
infiltrated_VBD
into_IN
human_JJ
squamous_JJ
cell_NN
carcinomas_NNS
of_IN
the_DT
head_NN
and_CC
neck_NN
during_IN
radiation_NN
therapy_NN
and_CC
its_PRP$
clinical_JJ
significance_NN
._.

C-fos_NN
has_VBZ
been_VBN
reported_VBN
to_TO
be_VB
one_CD
of_IN
the_DT
immediate_JJ
early_JJ
genes_NNS
in_IN
signal_NN
transduction_NN
systems_NNS
after_IN
many_JJ
kinds_NNS
of_IN
stresses_NNS
,_,
including_VBG
ionizing_VBG
radiation_NN
._.

Changes_NNS
in_IN
c-fos_NN
expression_NN
induced_VBN
by_IN
radiation_NN
therapy_NN
in_IN
tumor_NN
tissues_NNS
have_VBP
not_RB
yet_RB
been_VBN
reported_VBN
._.

In_IN
this_DT
study_NN
,_,
we_PRP
have_VBP
attempted_VBN
to_TO
determine_VB
whether_IN
c-fos_NN
expression_NN
is_VBZ
induced_VBN
by_IN
radiotherapy_NN
in_IN
human_JJ
squamous_JJ
cell_NN
carcinomas_NNS
of_IN
the_DT
head_NN
and_CC
neck_NN
and_CC
to_TO
establish_VB
a_DT
possible_JJ
correlation_NN
between_IN
c-fos_NN
expression_NN
and_CC
the_DT
therapeutic_JJ
effects_NNS
of_IN
radiation_NN
therapy_NN
._.

Twenty-seven_CD
patients_NNS
with_IN
tumors_NNS
of_IN
the_DT
oral_JJ
cavity_NN
,_,
oropharynx_NN
,_,
and_CC
maxillary_JJ
sinus_NN
were_VBD
examined_VBN
,_,
all_DT
of_IN
which_WDT
were_VBD
confirmed_VBN
as_IN
squamous_JJ
cell_NN
carcinomas_NNS
._.

After_IN
obtaining_VBG
the_DT
patients_NNS
'_POS
informed_VBN
consent_NN
,_,
biopsies_NNS
were_VBD
performed_VBN
before_IN
treatment_NN
and_CC
at_IN
doses_NNS
of_IN
4_CD
,_,
10_CD
,_,
and_CC
20_CD
Gy_NN
of_IN
radiotherapy_NN
,_,
and_CC
the_DT
specimens_NNS
were_VBD
preserved_VBN
in_IN
liquid_JJ
nitrogen_NN
for_IN
further_JJ
examination_NN
._.

Serial_JJ
sectioning_NN
of_IN
6_CD
micrometer_NN
was_VBD
performed_VBN
using_VBG
a_DT
cryostat_NN
,_,
and_CC
samples_NNS
were_VBD
immunohistochemically_RB
stained_VBN
using_VBG
the_DT
streptoavidin-biotin_JJ
peroxidase_NN
method_NN
and_CC
a_DT
monoclonal_JJ
antibody_NN
against_IN
c-fos_NN
._.

Three_CD
of_IN
the_DT
27_CD
patients_NNS
with_IN
squamous_JJ
cell_NN
carcinoma_NN
showed_VBD
slight_JJ
expression_NN
of_IN
c-fos_NN
in_IN
their_PRP$
tumor_NN
cells_NNS
before_IN
and\/or_CC
at_IN
4_CD
or_CC
10_CD
Gy_NN
of_IN
radiotherapy_NN
._.

The_DT
tumors_NNS
showed_VBD
high_JJ
radiosensitivity_NN
._.

Concerning_VBG
tumor-infiltrating_JJ
lymphocytes_NNS
,_,
the_DT
rate_NN
of_IN
moderate_JJ
or_CC
remarkable_JJ
grades_NNS
of_IN
c-fos-positive_JJ
lymphocytes_NNS
before_IN
radiotherapy_NN
and_CC
at_IN
radiation_NN
doses_NNS
of_IN
4_CD
,_,
10_CD
,_,
and_CC
20_CD
Gy_NN
was_VBD
8.0_CD
,_,
29.2_CD
,_,
4.8_CD
,_,
and_CC
0_CD
%_NN
,_,
respectively_RB
._.

The_DT
relationship_NN
between_IN
the_DT
immunohistochemical_JJ
findings_NNS
and_CC
the_DT
antitumor_JJ
effect_NN
at_IN
a_DT
radiation_NN
dose_NN
of_IN
20_CD
Gy_NN
was_VBD
examined_VBN
on_IN
the_DT
corresponding_JJ
H_NN
&_JJ
E-stained_JJ
sections_NNS
._.

In_IN
patients_NNS
whose_WP$
infiltration_NN
of_IN
c-fos-positive_JJ
lymphocytes_NNS
into_IN
tumor_NN
tissues_NNS
were_VBD
moderate_JJ
or_CC
remarkable_JJ
at_IN
4_CD
Gy_NN
of_IN
radiotherapy_NN
,_,
the_DT
tumors_NNS
responded_VBD
significantly_RB
well_RB
to_TO
radiation_NN
therapy_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.025_CD
,_,
chi2_NN
test_NN
-RRB-_-RRB-
,_,
and_CC
the_DT
patients_NNS
took_VBD
a_DT
significantly_RB
favorable_JJ
clinical_JJ
course_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
,_,
chi2_NN
test_NN
-RRB-_-RRB-
._.

In_IN
a_DT
sample_NN
from_IN
one_CD
of_IN
the_DT
patients_NNS
,_,
c-fos-positive_JJ
lymphocytes_NNS
were_VBD
identified_VBN
as_IN
CD4_NN
positive_JJ
and_CC
CD8_NN
negative_JJ
._.

Therefore_RB
,_,
the_DT
high_JJ
radiosensitivity_NN
of_IN
squamous_JJ
cell_NN
carcinomas_NNS
in_IN
our_PRP$
samples_NNS
could_MD
be_VB
explained_VBN
by_IN
an_DT
overexpression_NN
of_IN
c-fos_NN
in_IN
the_DT
tumor-infiltrating_JJ
lymphocytes_NNS
induced_VBN
by_IN
small_JJ
doses_NNS
of_IN
radiation_NN
therapy_NN
,_,
and_CC
these_DT
activated_VBN
lymphocytes_NNS
exerted_VBD
a_DT
cytotoxic_JJ
effect_NN
against_IN
the_DT
cancer_NN
cells_NNS
._.

